Michael P Curry

12PUBLICATIONS
38CO-AUTHORS
Medical biochemistry - lipidsRadiation therapyMicroelectromechanical systems (MEMS)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 26, 2025
Methods and Validation of Velacur Determined Fat Fraction in patients with MASLD.

Mohammad Honarvar, Julio Lobo, Caitlin Schneider

|May 07, 2024
Efficacy and Safety of Radiation Segmentectomy with 90Y Resin Microspheres for Hepatocellular Carcinoma.

Ammar Sarwar, M Saad Malik, Nhi H Vo

|Mar 22, 2024
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD.

Rohit Loomba, Alnoor Ramji, Tarek Hassanein

|Jan 26, 2024
The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study.

Michael P Curry, Edward Tam, Caitlin Schneider

|Jan 05, 2024
A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis.

Zachary Fricker, Gordon Jiang, Het Patel

|Oct 06, 2023
Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin.

Ethan M Weinberg, Florence Wong, Hugo E Vargas

Pageof 2

Frequent Collaborators

3 joint publications

Stephen Chris Pappas

3 joint publications

K Rajender Reddy

3 joint publications

Nezam H Afdhal

3 joint publications

Tarek Hassanien